Back

Low-dose mineralocorticoid receptor antagonists improve outcomes without dose escalation in elderly TEER patients with systolic heart failure

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Interventions for structural disease and stroke Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Teruhiko Imamura

University of Toyama, Toyama (Japan)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor C. Nakai (Albany, US)
Abstract Slides Video
Presentation thumbnail
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor A. Reina (Seville, ES)
Abstract
Presentation thumbnail
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Interventions for structural disease and stroke

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
thumbnail
Congress Presentation
When and who to refer for transcatheter therapies?
thumbnail
Congress Presentation
MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy